Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-110484
Filing Date
2024-09-30
Accepted
2024-09-30 19:10:58
Documents
2
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2999
2 EX-24 vrdn-ex24.htm EX-24 11123
  Complete submission text file 0000950170-24-110484.txt   16027
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Mahoney Stephen F. (Reporting) CIK: 0001741389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 241340877